OBSOLETE: Rare variants of adenocarcinoma of the corpus uteri

Rare variants of adenocarcinoma of the corpus uteri refers to uncommon subtypes of cancer that develop in the lining (endometrium) or body of the uterus. While the most common type of uterine cancer is the typical endometrioid adenocarcinoma, these rare variants include unusual cell types or growth patterns that behave differently from the common form. Examples of rare variants may include clear cell carcinoma, serous carcinoma, mucinous carcinoma, squamous cell carcinoma, undifferentiated carcinoma, and mixed types of the uterine body. These rare subtypes often tend to be more aggressive than the common type of endometrial cancer and may be diagnosed at a more advanced stage. Symptoms are similar to other uterine cancers and most commonly include abnormal vaginal bleeding, especially bleeding after menopause, unusual vaginal discharge, pelvic pain, or pain during intercourse. Some women may also experience unexplained weight loss or a feeling of fullness in the lower abdomen. Treatment typically involves surgery to remove the uterus (hysterectomy), often along with removal of the ovaries and fallopian tubes. Depending on the stage and specific subtype, additional treatments such as chemotherapy, radiation therapy, or hormonal therapy may be recommended. Because these are rare variants, treatment plans are often tailored to the individual and may differ from standard endometrial cancer protocols. Note that this Orphanet entry is marked as 'OBSOLETE,' meaning the classification may have been reorganized or merged into other disease entries in current medical databases.

Bring these to your next appointment

• Q1.What specific rare subtype of uterine cancer do I have, and how does it differ from the common type?,What stage is my cancer, and what does that mean for my treatment options?,Should I have genetic testing to check for Lynch syndrome or other hereditary cancer syndromes?,What treatment plan do you recommend, and what are the potential side effects?,Am I eligible for any clinical trials that focus on my specific cancer subtype?,What is my prognosis, and how will we monitor for recurrence after treatment?,Should my family members be screened for hereditary cancer risk?

Common questions about OBSOLETE: Rare variants of adenocarcinoma of the corpus uteri